Fatty liver progression and carcinogenesis: Beware of pathogenic T cells
- PMID: 35590223
- DOI: 10.1016/j.medj.2021.04.020
Fatty liver progression and carcinogenesis: Beware of pathogenic T cells
Abstract
The pathogenesis of nonalcoholic steatohepatitis (NASH) and NASH-related liver cancer is incompletely understood. In the recent issue of Nature, two studies by Dudek et al. and Pfister et al. revealed the critical role of CD8 T cells in instigating liver damage and promoting liver cancer in NASH.1,2.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.Nature. 2021 Apr;592(7854):450-456. doi: 10.1038/s41586-021-03362-0. Epub 2021 Mar 24. Nature. 2021. PMID: 33762733 Free PMC article.
-
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.Nature. 2021 Apr;592(7854):444-449. doi: 10.1038/s41586-021-03233-8. Epub 2021 Mar 24. Nature. 2021. PMID: 33762736
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials